medline.ch Respirationstrakt Neoplasie

	Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011-2023): A Retrospective Cohort Study. Med J Aust Samuel E, Paul E, Lloyd M, Tissera S, Underhill C, Parakh S, Parente P, Olesen I, Torres J, See K, Wright GM, Langton D, John T, Conron M, Bartlett J, Atkin N, Zeps N, Harden SV, Faisal W, Zalcberg JR, Stirling RG. PMID: 42610726 [PubMed - indexed for MEDLINE]
	Multidisciplinary Team Care for Early-Stage Lung Cancer in Low- and Middle-Income Countries and Emerging Economies: Current Position and Call for Action. Thorac Cancer Araujo LH, Orlandi FJ, Azam A, Viola L, Elkerm Y, Alatorre-Alexander J, Ba, Lyons GA, Li X, Lam Quoc T, Munshi A, Gonzalez F. PMID: 42610673 [PubMed - indexed for MEDLINE]
	A Single-Center Comparative Study of the c-MET Immunohistochemistry SP44 and LBP4 Assays in Chinese Non-Small Cell Lung Cancer (NSCLC) Cohort. Appl Immunohistochem Mol Morphol Wang Y, Liang Z, Song S, Liu B, Zhang H, Jiang L, Su Y, Wang W. PMID: 42610370 [PubMed - as supplied by publisher]
	Correction: 18F-FDG PET/CT for predicting major pathological response to neoadjuvant therapy in non-small cell lung cancer: a meta-analysis. Front Oncol Wu Y, Hu B, Liu D, Meng H. PMID: 42609794 [PubMed]
	Impact of lung cancer discovery mode on cancer outcomes: data from the KBP-2020-CPHG study. ERJ Open Res Grolleau E, Couraud S, Maurer C, Kraemer JP, Peloni JM, Raymond S, Le Floch H, Banciu N, Letierce A, Debieuvre D. PMID: 42609744 [PubMed]
	Dynamic Granulocyte Turnover Inferred From cfDNA Methylation Predicts Immunotherapy Benefit in Liver-Metastatic Small Cell Lung Cancer: A Prospective Biomarker Study. MedComm (2020) Tang N, Shang X, Sun Y, Zhang Y, Zhou H, Ye S, Tang X, Guo J, Zhang X, Gao X, Wang Z, Wang H. PMID: 42609700 [PubMed]
	Synergistic effects and clinical utilization of radioimmunotherapy for brain metastases from driver mutation-negative non-small cell lung cancer. Precis Radiat Oncol Yu S, Ni J, Chen H, Weng N, Yang X, Chu X, Chu L, Zhu Z. PMID: 42609674 [PubMed - as supplied by publisher]
	Toxicity of BEP chemotherapy in germ cell tumors: focus on immune-mediated bleomycin pulmonary toxicity in comparison with EP and VIP regimens. Front Immunol Olah P, Celec P, Vlkova B, Rejlekova K. PMID: 42609598 [PubMed - indexed for MEDLINE]
	Squamous transformation of EGFR-mutant lung adenocarcinoma after EGFR-TKI therapy: clonal continuity, tissue-based diagnosis, and therapeutic evidence gaps. Front Oncol Zhou L, Zhang P, Liu Q, Wang L. PMID: 42609500 [PubMed]
	Predictive value of nutritional biomarkers for immune checkpoint inhibitor efficacy in patients with non-small cell lung cancer. Front Nutr Zhang W, Liu X. PMID: 42609359 [PubMed]
	A dual-validated machine learning model for predicting 3-year mortality in atypical pulmonary carcinoid, a rare neuroendocrine tumor. Front Endocrinol (Lausanne) Chen Y, Luo X, Zhang H, Zhou J, Yu Y, Yang G, Chen J. PMID: 42609244 [PubMed - indexed for MEDLINE]
	Development, Co-Design and Pilot Testing of Resources to Support Informed Decision-Making for Lung Cancer Screening in Australia: A Study Engaging Diverse Communities and Expert Healthcare Professionals. Health Expect Dodd RH, McFadden K, Weber M, Mouwad D, Yap ML, Dickson M, Sheriff S, Stone E, Zachariah D, King A, Rankin NM. PMID: 42609114 [PubMed - indexed for MEDLINE]
	Screening Potential Diagnostic Biomarkers of Lung Adenocarcinoma Related to Immune Infiltration Based on Single-Cell Proteomic Integration Analysis. Can Respir J Xu N, Zhang Y, Lian Q, Cai Y, Ni M. PMID: 42608948 [PubMed - indexed for MEDLINE]
	Integrating Cardiovascular Screening in Lung Cancer Screening. Br J Radiol Mozafary M, Rezaeifar M, Naghavi M, Kazerooni EA, Stillman AE, Raggi P. PMID: 42608820 [PubMed - as supplied by publisher]
	Clinical significance of miRNAs and exosomal miRNAs in non-small cell lung cancer: diagnostic, prognostic, and therapeutic perspectives. J Hum Genet Khan IA, Gupta S, Meena JP. PMID: 42608544 [PubMed - as supplied by publisher]
	When rare becomes real: diagnostic challenges and use of a multidisciplinary team-based decision in primary pulmonary synovial sarcoma. BMJ Case Rep Quizon BLM, Mangugan NA, Ambrocio GPLC, Fernandez LC. PMID: 42608070 [PubMed - indexed for MEDLINE]
	Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw Stevenson J, Riely GJ, Wood DE, Aisner DL, Axtell AL, Bauman JR, Bharat A, Chang JY, Desai A, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Juloori A, Lackner RP, Lanuti M, Levy B, Lin J, Loo BW Jr, Lovly CM, Maldonado F, Morgensztern D, Mullikin TC, Ng T, Owen D, Owen DH, Patil T, Polanco PM, Riess J, Ruano Mendez AL, Shapiro TA, Singh AP, Tam A, Tanvetyanon T, Yanagawa J, Yau E, Yun K, Gregory K, Hang L. PMID: 42607715 [PubMed - indexed for MEDLINE]
	Current Surgical Perspectives for Pleural Mesothelioma. J Natl Compr Canc Netw Esteva S, Abtin F, Fishbein GA, Cameron RB, Burt BM, Yanagawa J. PMID: 42607714 [PubMed - indexed for MEDLINE]
	Afatinib combined with oral metronomic vinorelbine as second-line treatment for advanced lung squamous cell carcinoma: a retrospective cohort study. Neoplasma Yin C, Li B, Lin X, Zhang A, Peng Y, Tang J, Li X. PMID: 42606915 [PubMed - as supplied by publisher]
	Neural regulation in lung cancer: from mechanisms to new therapeutic perspectives. Clin Exp Med Zhao J, Han Y, Li Y, Li Y, Sun Y, Bai Y, Chen J, Han C, Yan Y, Zhou C, Liu C. PMID: 42606738 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 162361

Seite 1 von 8119



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung